Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (81-90 of 441) with videos related to

Pageof 45
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
The impact of human immunodeficiency virus on viral hepatitisVincent Mallet, Anaïs Vallet-Pichard, Stanislas Pol
Nature Reviews. Gastroenterology & Hepatology|January 18, 2018
Extrahepatic cancers and chronic HCV infectionStanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine
Alimentary Pharmacology & Therapeutics|April 8, 2021
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' replyStanislas Pol, Clovis Lusivika Nzinga, Fabrice Carrat
La Revue Du Praticien|April 2, 2011
[Assessment and reversibility of liver fibrosis in viral hepatitis]Anaïs Vallet-Pichard, Stanislas Pol, Vincent Mallet
Presse Medicale (Paris, France : 1983)|January 16, 2010
New trends in hepatitis C managementVincent Mallet, Anaïs Vallet-Pichard, Stanislas Pol
Gastroenterologie Clinique Et Biologique|December 17, 2002
[Atheroma and hepatitis C virus]Anaïs Vallet-Pichard, Hélène Fontaine, Stanislas Pol
Hepatic Medicine : Evidence and Research|March 29, 2016
Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real lifeStanislas Pol, Marion Corouge, Anaïs Vallet-Pichard
Presse Medicale (Paris, France : 1983)|November 24, 2019
[Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health]Anaïs Vallet-Pichard, Lucia Parlati, Stanislas Pol
Hepatology (Baltimore, Md.)|August 31, 2006
FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patientsAnaïs Vallet-Pichard, Vincent Mallet, Stanislas Pol
Journal of Hepatology|October 22, 2008
Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis CMatthew L Albert, Jérémie Decalf, Stanislas Pol
Pageof 45

Showing results (81-90 of 441) with videos related to

Sort By:
Pageof 45
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
The impact of human immunodeficiency virus on viral hepatitisVincent Mallet, Anaïs Vallet-Pichard, Stanislas Pol
Nature Reviews. Gastroenterology & Hepatology|January 18, 2018
Extrahepatic cancers and chronic HCV infectionStanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine
Alimentary Pharmacology & Therapeutics|April 8, 2021
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' replyStanislas Pol, Clovis Lusivika Nzinga, Fabrice Carrat
La Revue Du Praticien|April 2, 2011
[Assessment and reversibility of liver fibrosis in viral hepatitis]Anaïs Vallet-Pichard, Stanislas Pol, Vincent Mallet
Presse Medicale (Paris, France : 1983)|January 16, 2010
New trends in hepatitis C managementVincent Mallet, Anaïs Vallet-Pichard, Stanislas Pol
Gastroenterologie Clinique Et Biologique|December 17, 2002
[Atheroma and hepatitis C virus]Anaïs Vallet-Pichard, Hélène Fontaine, Stanislas Pol
Hepatic Medicine : Evidence and Research|March 29, 2016
Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real lifeStanislas Pol, Marion Corouge, Anaïs Vallet-Pichard
Presse Medicale (Paris, France : 1983)|November 24, 2019
[Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health]Anaïs Vallet-Pichard, Lucia Parlati, Stanislas Pol
Hepatology (Baltimore, Md.)|August 31, 2006
FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patientsAnaïs Vallet-Pichard, Vincent Mallet, Stanislas Pol
Journal of Hepatology|October 22, 2008
Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis CMatthew L Albert, Jérémie Decalf, Stanislas Pol
Pageof 45